Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands

European Journal of Pharmacology

Volumn 479, Issue 1-3, 2003, Pages 139-152

  Gulley, Joshua M ^a   Zahniser, Nancy R ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

DAT (dopamine transporter); Functional regulation; Presynaptic receptor; Substrate mediated regulation; Trafficking

Indexed keywords

2,6 DIAMINO N [[1 (1 OXOTRIDECYL) 2 PIPERIDYL]METHYL]HEXANAMIDE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; 4 AMINOBUTYRIC ACID B RECEPTOR; AMPHETAMINE; BISINDOLYLMALEIMIDE; COCAINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE TRANSPORTER; KAPPA OPIATE RECEPTOR; LIGAND; MAZINDOL; METABOTROPIC RECEPTOR; METHAMPHETAMINE; N (4 ISOTHIOCYANATOPHENETHYL)SPIPERONE; NICOTINIC RECEPTOR; PRESYNAPTIC RECEPTOR; PROTEIN KINASE C INHIBITOR; PSYCHOSTIMULANT AGENT; QUINPIROLE; SEROTONIN RECEPTOR; SIGMA OPIATE RECEPTOR; TYRAMINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANOXERINE;

BRAIN REGION; CONCENTRATION RESPONSE; DOPAMINE UPTAKE; DOWN REGULATION; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; HUMAN; MICRODIALYSIS; NONHUMAN; POTENTIOMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0242492013     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.08.064     Document Type: Article

References (147)

1. + dependence of the neuronal transport of dopamine. J. Neurochem. 59:1992;1795-1804.
2. Amejdki-Chab N., Costentin J., Bonnet J.J. Kinetic analysis of the chloride dependence of the neuronal uptake of dopamine and effect of anions on the ability of substrates to compete with the binding of the dopamine uptake inhibitor GBR 12783. J. Neurochem. 58:1992;793-800.
3. 2+-dependent chloride current in the immature Xenopus oocyte. J. Physiol. 342:1983;309-325.
4. Batchelor M., Schenk J.O. Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine. J. Neurosci. 18:1998;10304-10309.
5. Beckman M.L., Quick M.W. Neurotransmitter transporters: regulators of function and functional regulation. J. Membr. Biol. 164:1998;1-10.
6. Beckman M.L., Bernstein E.M., Quick M.W. Multiple G protein-coupled receptors initiate protein kinase C redistribution of GABA transporters in hippocampal neurons. J. Neurosci. 19:1999;RC9.
7. Benmansour S., Tejani-Butt S.M., Brunswick D.J. Lack of effect of high-dose cocaine on monamine uptake sites in rat brain measured by quantitative autoradiography. Psychopharmacology (Berl.). 106:1992;459-462.
8. Benoit-Marand M., Jaber M., Gonon F. Release and elimination of dopamine in vivo in mice lacking the dopamine transporter: functional consequences. Eur. J. Neurosci. 12:2000;2985-2992.
9. Benoit-Marand M., Borrelli E., Gonon F. Inhibition of dopamine release via presynaptic D2 receptors: time course and functional characteristics in vivo. J. Neurosci. 21:2001;9134-9141.
10. Berman S.B., Zigmond M.J., Hastings T.G. Modification of dopamine transporter function: effect of reactive oxygen species and dopamine. J. Neurochem. 67:1996;593-600.
11. Blakely R.D., Bauman A.L. Biogenic amine transporters: regulation in flux. Curr. Opin. Neurobiol. 10:2000;328-336.
12. Bradberry C.W. Acute and chronic dopamine dynamics in a nonhuman primate model of recreational cocaine use. J. Neurosci. 20:2000;7109-7115.
13. Carvelli L., Moron J.A., Kahlig K.M., Ferrer J.V., Sen N., Lechleiter J.D., Leeb-Lundberg L.M., Merrill G., Lafer E.M., Ballou L.M., Shippenberg T.S., Javitch J.A., Lin R.Z., Galli A. PI 3-kinase regulation of dopamine uptake. J. Neurochem. 81:2002;859-869.
14. Cass W.A., Gerhardt G.A. Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake. Neurosci. Lett. 176:1994;259-263.
15. Cass W.A., Gerhardt G.A., Mayfield R.D., Curella P., Zahniser N.R. Differences in dopamine clearance and diffusion in rat striatum and nucleus accumbens following systemic cocaine administration. J. Neurochem. 59:1992;259-266.
16. Cass W.A., Gerhardt G.A., Gillespie K., Curella P., Mayfield R.D., Zahniser N.R. Reduced clearance of exogenous dopamine in rat nucleus accumbens, but not in dorsal striatum, following cocaine challenge in rats withdrawn from repeated cocaine administration. J. Neurochem. 61:1993;273-283.
17. Cass W.A., Zahniser N.R., Flach K.A., Gerhardt G.A. Clearance of exogenous dopamine in rat dorsal striatum and nucleus accumbens: role of metabolism and effects of locally applied uptake inhibitors. J. Neurochem. 61:1993;2269-2278.
18. Chang M.Y., Lee S.H., Kim J.H., Lee K.H., Kim Y.S., Son H., Lee Y.S. Protein kinase C-mediated functional regulation of dopamine transporter is not achieved by direct phosphorylation of the dopamine transporter protein. J. Neurochem. 77:2001;754-761.
19. Chefer V.I., Shippenberg T.S. Changes in basal and cocaine-evoked extracellular dopamine uptake and release in the rat nucleus accumbens during early abstinence from cocaine: quantitative determination under transient conditions. Neuroscience. 112:2002;907-919.
20. Chefer V.I., Moron J.A., Hope B., Rea W., Shippenberg T.S. Kappa-opioid receptor activation prevents alterations in mesocortical dopamine neurotransmission that occur during abstinence from cocaine. Neuroscience. 101:2000;619-627.
21. Chen N., Trowbridge C.G., Justice J.B. Jr. Cationic modulation of human dopamine transporter: dopamine uptake and inhibition of uptake. J. Pharmacol. Exp. Ther. 290:1999;940-949.
22. Copeland B.J., Vogelsberg V., Neff N.H., Hadjiconstantinou M. Protein kinase C activators decrease dopamine uptake into striatal synaptosomes. J. Pharmacol. Exp. Ther. 277:1996;1527-1532.
23. Daniels G.M., Amara S.G. Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters. J. Biol. Chem. 274:1999;35794-35801.
24. David D.J., Zahniser N.R., Hoffer B.J., Gerhardt G.A. In vivo electrochemical studies of dopamine clearance in subregions of rat nucleus accumbens: differential properties of the core and shell. Exp. Neurol. 153:1998;277-286.
25. Daws L.C., Callaghan P.D., Moron J.A., Kahlig K.M., Shippenberg T.S., Javitch J.A., Galli A. Cocaine increases dopamine uptake and cell surface expression of dopamine transporters. Biochem. Biophys. Res. Commun. 290:2002;1545-1550.
26. Deken S.L., Wang D., Quick M.W. Plasma membrane GABA transporters reside on distinct vesicles and undergo rapid regulated recycling. J. Neurosci. 23:2003;1563-1568.
27. Derbez A.E., Mody R.M., Werling L.L. Sigma(2)-receptor regulation of dopamine transporter via activation of protein kinase C. J. Pharmacol. Exp. Ther. 301:2002;306-314.
28. Dickinson S.D., Sabeti J., Larson G.A., Giardina K., Rubinstein M., Kelly M.A., Grandy D.K., Low M.J., Gerhardt G.A., Zahniser N.R. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J. Neurochem. 72:1999;148-156.
29. Drew A.E., Werling L.L. Protein kinase C regulation of dopamine transporter initiated by nicotinic receptor activation in slices of rat prefrontal cortex. J. Neurochem. 77:2001;839-848.
30. Drew A.E., Derbez A.E., Werling L.L. Nicotinic receptor-mediated regulation of dopamine transporter activity in rat prefrontal cortex. Synapse. 38:2000;10-16.
31. Earles C., Schenk J.O. Multisubtrate mechanism for the inward transport of dopamine by the human dopamine transporter expressed in HEK cells and its inhibition by cocaine. Synapse. 33:1999;230-238.
32. Eshleman A.J., Neve R.L., Janowsky A., Neve K.A. Characterization of a recombinant human dopamine transporter in multiple cell lines. J. Pharmacol. Exp. Ther. 274:1995;276-283.
33. Farfel G.M., Kleven M.S., Woolverton W.L., Seiden L.S., Perry B.D. Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey. Brain Res. 578:1992;235-243.
34. Fleckenstein A.E., Metzger R.R., Wilkins D.G., Gibb J.W., Hanson G.R. Rapid and reversible effects of methamphetamine on dopamine transporters. J. Pharmacol. Exp. Ther. 282:1997;834-838.
35. Fleckenstein A.E., Haughey H.M., Metzger R.R., Kokoshka J.M., Riddle E.L., Hanson J.E., Gibb J.W., Hanson G.R. Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function. Eur. J. Pharmacol. 382:1999;45-49.
36. Gainetdinov R.R., Caron M.G. Monoamine transporters: from genes to behavior. Annu. Rev. Pharmacol. Toxicol. 43:2003;261-284.
37. Garris P.A., Wightman R.M. Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study. J. Neurosci. 14:1994;442-450.
38. Giros B., Caron M.G. Molecular characterization of the dopamine transporter. Trends Pharmacol. Sci. 14:1993;43-49.
39. Giros B., el Mestikawy S., Godinot N., Zheng K., Han H., Yang-Feng T., Caron M.G. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol. Pharmacol. 42:1992;383-390.
40. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;606-612.
41. Gulley J.M., Doolen S., Zahniser N.R. Brief, repeated exposure to substrates down-regulates dopamine transporter function in Xenopus oocytes in vitro and rat dorsal striatum in vivo. J. Neurochem. 83:2002;400-411.
42. Hicke L. Gettin' down with ubiquitin: turning off cell-surface receptors, transporters and channels. Trends Cell Biol. 9:1999;107-112.
43. Ho M., Segre M. Dopamine uptake by mouse neuroblastoma N1E-115 cells stably expressing human dopamine transporter is differentially inhibited by anti-idiotypic ab2beta antibodies mimicking the configuration of cocaine. Brain Res. 872:2000;231-235.
44. Ho M., Segre M. Individual and combined effects of ethanol and cocaine on the human dopamine transporter in neuronal cell lines. Neurosci. Lett. 299:2001;229-233.
45. Hoffman B.J., Hansson S.R., Mezey E., Palkovits M. Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system. Front. Neuroendocrinol. 19:1998;187-231.
46. Hoffman A.F., Zahniser N.R., Lupica C.R., Gerhardt G.A. Voltage-dependency of the dopamine transporter in the rat substantia nigra. Neurosci. Lett. 260:1999;105-108.
47. Huang C.L., Chen H.C., Huang N.K., Yang D.M., Kao L.S., Chen J.C., Lai H.L., Chern Y. Modulation of dopamine transporter activity by nicotinic acetylcholine receptors and membrane depolarization in rat pheochromocytoma PC12 cells. J. Neurochem. 72:1999;2437-2444.
48. max. J. Neurochem. 68:1997;225-232.
49. Hurd Y.L., Herkenham M. Molecular alterations in the neostriatum of human cocaine addicts. Synapse. 13:1993;357-369.
50. 2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum. Brain Res. 698:1995;204-208.
51. 1A receptor agonist, inhibits amphetamine-induced dopamine release in rat striatum and nucleus accumbens. Eur. J. Pharmacol. 287:1995;179-184.
52. Ingram S.L., Prasad B.M., Amara S.G. Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons. Nat. Neurosci. 5:2002;971-978.
53. Izenwasser S., Acri J.B., Kunko P.M., Shippenberg T. Repeated treatment with the selective κ-opioid agonist U-69593 produces a marked depletion of dopamine D2 receptors. Synapse. 30:1998;275-283.
54. Jaber M., Dumartin B., Sagne C., Haycock J.W., Roubert C., Giros B., Bloch B., Caron M.G. Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter. Eur. J. Neurosci. 11:1999;3499-3511.
55. Jones S.R., Lee T.H., Wightman R.M., Ellinwood E.H. Effects of intermittent and continuous cocaine administration on dopamine release and uptake regulation in the striatum: in vitro voltammetric assessment. Psychopharmacology (Berl.). 126:1996;331-338.
56. Jones S.R., Gainetdinov R.R., Jaber M., Giros B., Wightman R.M., Caron M.G. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc. Natl. Acad. Sci. U. S. A. 95:1998;4029-4034.
57. Jones S.R., Gainetdinov R.R., Wightman R.M., Caron M.G. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neurosci. 18:1998;1979-1986.
58. Jones S.R., Gainetdinov R.R., Hu X.T., Cooper D.C., Wightman R.M., White F.J., Caron M.G. Loss of autoreceptor functions in mice lacking the dopamine transporter. Nat. Neurosci. 2:1999;649-655.
59. Justice J.B. Jr. Quantitative microdialysis of neurotransmitters. J. Neurosci. Methods. 48:1993;263-276.
60. Kalivas P.W., Duffy P. Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse. 5:1990;48-58.
61. Kalivas P.W., Duffy P. Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J. Neurosci. 13:1993;266-275.
62. Kantor L., Gnegy M.E. Protein kinase C inhibitors block amphetamine-mediated dopamine release in rat striatal slices. J. Pharmacol. Exp. Ther. 284:1998;592-598.
63. Kilty J.E., Lorang D., Amara S.G. Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science. 254:1991;578-579.
64. Kim S., Westphalen R., Callahan B., Hatzidimitriou G., Yuan J., Ricaurte G.A. Toward development of an in vitro model of methamphetamine-induced dopamine nerve terminal toxicity. J. Pharmacol. Exp. Ther. 293:2000;625-633.
65. Kimmel H.L., Joyce A.R., Carroll F.I., Kuhar M.J. Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat. J. Pharmacol. Exp. Ther. 298:2001;129-140.
66. Kimmel H.L., Carroll F.I., Kuhar M.J. Withdrawal from repeated cocaine alters dopamine transporter protein turnover in the rat striatum. J. Pharmacol. Exp. Ther. 304:2003;15-21.
67. Kitayama S., Dohi T., Uhl G.R. Phorbol esters alter functions of the expressed dopamine transporter. Eur. J. Pharmacol. 268:1994;115-119.
68. Kiyatkin E.A., Kiyatkin D.E., Rebec G.V. Phasic inhibition of dopamine uptake in nucleus accumbens induced by intravenous cocaine in freely behaving rats. Neuroscience. 98:2000;729-741.
69. Koff J.M., Shuster L., Miller L.G. Chronic cocaine administration is associated with behavioral sensitization and time-dependent changes in striatal dopamine transporter binding. J. Pharmacol. Exp. Ther. 268:1994;277-282.
70. Kokoshka J.M., Vaughan R.A., Hanson G.R., Fleckenstein A.E. Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters. Eur. J. Pharmacol. 361:1998;269-275.
71. 2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. Brain Res. 972:2003;216-221.
72. Langer S.Z. Twenty-five years since the discovery of presynaptic receptors: present knowledge and future perspectives. Trends Pharmacol. Sci. 18:1997;95-99.
73. Letchworth S.R., Daunais J.B., Hedgecock A.A., Porrino L.J. Effects of chronic cocaine administration on dopamine transporter mRNA and protein in the rat. Brain Res. 750:1997;214-222.
74. Letchworth S.R., Nader M.A., Smith H.R., Friedman D.P., Porrino L.J. Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys. J. Neurosci. 21:2001;2799-2807.
75. Lew R., Patel A., Vaughn R.A., Wilson A., Kuhar M.J. Microheterogeneity of dopamine transporters in rat striatum and nucleus accumbens. Brain Res. 584:1992;266-271.
76. Little K.Y., Kirkman J.A., Carroll F.I., Clark T.B., Duncan G.E. Cocaine use increases. Brain Res. 628:1993;17-25.
77. Little K.Y., Zhang L., Desmond T., Frey K.A., Dalack G.W., Cassin B.J. Striatal dopaminergic abnormalities in human cocaine users. Am. J. Psychiatry. 156:1999;238-245.
78. Little K.Y., Elmer L.W., Zhong H., Scheys J.O., Zhang L. Cocaine induction of dopamine transporter trafficking to the plasma membrane. Mol. Pharmacol. 61:2002;436-445.
79. Loder M.K., Melikian H.E. The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines. J. Biol. Chem. 278:2003;22168-22174.
80. 123I]β-CIT SPECT. Am. J. Psychiatry. 155:1998;832-834.
81. Marshall J.F., O'Dell S.J., Navarrete R., Rosenstein A.J. Dopamine high-affinity transport site topography in rat brain: major differences between dorsal and ventral striatum. Neuroscience. 37:1990;11-21.
82. Mash D.C., Staley J.K., Doepel F.M., Young S.N., Ervin F.R., Palmour R.M. Altered dopamine transporter densities in alcohol-preferring vervet monkeys. NeuroReport. 7:1996;457-462.
83. Mash D.C., Pablo J., Ouyang Q., Hearn W.L., Izenwasser S. Dopamine transport function is elevated in cocaine users. J. Neurochem. 81:2002;292-300.
84. May L.J., Wightman R.M. Heterogeneity of stimulated dopamine overflow within rat striatum as observed with in vivo voltammetry. Brain Res. 487:1989;311-320.
85. Mayfield R.D., Zahniser N.R. Dopamine D2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltage-independent. Mol. Pharmacol. 59:2001;113-121.
86. McElvain J.S., Schenk J.O. A multisubstrate mechanism of striatal dopamine uptake and its inhibition by cocaine. Biochem. Pharmacol. 43:1992;2189-2199.
87. Meiergerd S.M., Patterson T.A., Schenk J.O. D2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo. J. Neurochem. 61:1993;764-767.
88. Melikian H.E., Buckley K.M. Membrane trafficking regulates the activity of the human dopamine transporter. J. Neurosci. 19:1999;7699-7710.
89. 3H-GBR 12935. J. Neural Transm. Gen. Sect. 87:1992;1-14.
90. Metzger R.R., Hanson G.R., Gibb J.W., Fleckenstein A.E. 3-4-Methylenedioxymethamphetamine-induced acute changes in dopamine transporter function. Eur. J. Pharmacol. 349:1998;205-210.
91. Metzger R.R., Haughey H.M., Wilkins D.G., Gibb J.W., Hanson G.R., Fleckenstein A.E. Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia. J. Pharmacol. Exp. Ther. 295:2000;1077-1085.
92. Ng J.P., Hubert G.W., Justice J.B. Jr. Increased stimulated release and uptake of dopamine in nucleus accumbens after repeated cocaine administration as measured by in vivo voltammetry. J. Neurochem. 56:1991;1485-1492.
93. Ng J.P., Menacherry S.D., Liem B.J., Anderson D., Singer M., Justice J.B. Jr. Anomalous effect of mazindol on dopamine uptake as measured by in vivo voltammetry and microdialysis. Neurosci. Lett. 134:1992;229-232.
94. Nicholson C. Interaction between diffusion and Michaelis-Menten uptake of dopamine after iontophoresis in striatum. Biophys. J. 68:1995;1699-1715.
95. Page G., Peeters M., Najimi M., Maloteaux J.M., Hermans E. Modulation of the neuronal dopamine transporter activity by the metabotropic glutamate receptor mGluR5 in rat striatal synaptosomes through phosphorylation mediated processes. J. Neurochem. 76:2001;1282-1290.
96. Parsons L.H., Justice J.B. Jr. Quantitative approaches to in vivo brain microdialysis. Crit. Rev. Neurobiol. 8:1994;189-220.
97. Parsons L.H., Smith A.D., Justice J.B. Jr. Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine. Synapse. 9:1991;60-65.
98. Parsons L.H., Schad C.A., Justice J.B. Jr. Co-administration of the D2 antagonist pimozide inhibits up-regulation of dopamine release and uptake induced by repeated cocaine. J. Neurochem. 60:1993;376-379.
99. Patel A., Uhl G., Kuhar M.J. Species differences in dopamine transporters: postmortem changes and glycosylation differences. J. Neurochem. 61:1993;496-500.
100. Peris J., Boyson S.J., Cass W.A., Curella P., Dwoskin L.P., Larson G., Lin L.H., Yasuda R.P., Zahniser N.R. Persistence of neurochemical changes in dopamine systems after repeated cocaine administration. J. Pharmacol. Exp. Ther. 253:1990;38-44.
101. Pilotte N.S., Sharpe L.G., Kuhar M.J. Withdrawal of repeated intravenous infusions of cocaine persistently reduces binding to dopamine transporters in the nucleus accumbens of Lewis rats. J. Pharmacol. Exp. Ther. 269:1994;963-969.
102. Pilotte N.S., Sharpe L.G., Rountree S.D., Kuhar M.J. Cocaine withdrawal reduces dopamine transporter binding in the shell of the nucleus accumbens. Synapse. 22:1996;87-92.
103. Povlock S.L., Schenk J.O. A multisubstrate kinetic mechanism of dopamine transport in the nucleus accumbens and its inhibition by cocaine. J. Neurochem. 69:1997;1093-1105.
104. Prasad B.M., Amara S.G. The dopamine transporter in mesencephalic cultures is refractory to physiological changes in membrane voltage. J. Neurosci. 21:2001;7561-7567.
105. Pristupa Z.B., McConkey F., Liu F., Man H.Y., Lee F.J., Wang Y.T., Niznik H.B. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter. Synapse. 30:1998;79-87.
106. Rabinovic A.D., Lewis D.A., Hastings T.G. Role of oxidative changes in the degeneration of dopamine terminals after injection of neurotoxic levels of dopamine. Neuroscience. 101:2000;67-76.
107. Rademacher T.W., Parekh R.B., Dwek R.A. Glycobiology. Annu. Rev. Biochem. 57:1988;785-838.
108. Raiteri M., Cerrito F., Cervoni A.M., Levi G. Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J. Pharmacol. Exp. Ther. 208:1979;195-202.
109. 3H] tropane to the dopamine uptake carrier. J. Neurochem. 61:1993;167-177.
110. Reith M.E., Xu C., Chen N.H. Pharmacology and regulation of the neuronal dopamine transporter. Eur. J. Pharmacol. 324:1997;1-10.
111. 3H]GBR 12935: binding characteristics. Brain Res. 540:1991;1-13.
112. Robinson M.B. Regulated trafficking of neurotransmitter transporters: common notes but different melodies. J. Neurochem. 80:2002;1-11.
113. Rothblat D.S., Schneider J.S. Regionally specific effects of haloperidol and clozapine on dopamine reuptake in the striatum. Neurosci. Lett. 228:1997;119-122.
114. Sabeti J., Gerhardt G.A., Zahniser N.R. Acute cocaine differentially alters accumbens and striatal dopamine clearance in low and high cocaine locomotor responders: behavioral and electrochemical recordings in freely moving rats. J. Pharmacol. Exp. Ther. 302:2002;1201-1211.
115. Sandoval V., Riddle E.L., Ugarte Y.V., Hanson G.R., Fleckenstein A.E. Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model. J. Neurosci. 21:2001;1413-1419.
116. Saunders C., Ferrer J.V., Shi L., Chen J., Merrill G., Lamb M.E., Leeb-Lundberg L.M., Carvelli L., Javitch J.A., Galli A. Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Proc. Natl. Acad. Sci. U. S. A. 97:2000;6850-6855.
117. Schmitz Y., Schmauss C., Sulzer D. Altered dopamine release and uptake kinetics in mice lacking D2 receptors. J. Neurosci. 22:2002;8002-8009.
118. Segal D.S., Kuczenski R. Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens. Brain Res. 577:1992;351-355.
119. Sharpe L.G., Pilotte N.S., Mitchell W.M., De Souza E.B. Withdrawal of repeated cocaine decreases autoradiographic. Eur. J. Pharmacol. 203:1991;141-144.
120. Shimada S., Kitayama S., Lin C.-L., Patel A., Nanthakumar E., Gregor P., Kuhar M., Uhl G. Cloning and expression of a cocaine-sensitive rat dopamine transporter complementary DNA. Science. 254:1991;576-578.
121. Sitte H.H., Huck S., Reither H., Boehm S., Singer E.A., Pifl C. Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. J. Neurochem. 71:1998;1289-1297.
122. Smith A.D., Justice J.B. The effect of inhibition of synthesis, release, metabolism and uptake on the microdialysis extraction fraction of dopamine. J. Neurosci. Methods. 54:1994;75-82.
123. Sonders M.S., Zhu S.J., Zahniser N.R., Kavanaugh M.P., Amara S.G. Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J. Neurosci. 17:1997;960-974.
124. Spielewoy C., Roubert C., Hamon M., Nosten-Bertrand M., Betancur C., Giros B. Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice. Behav. Pharmacol. 11:2000;279-290.
125. Staley J.K., Hearn W.L., Ruttenber A.J., Wetli C.V., Mash D.C. High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. J. Pharmacol. Exp. Ther. 271:1994;1678-1685.
126. Stamford J.A., Kruk Z.L., Miller J. In vivo voltammetric characterization of low affinity striatal dopamine uptake: drug inhibition profile and relation to dopaminergic innervation density. Brain Res. 373:1986;85-91.
127. Starke K., Gothert M., Kilbinger H. Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol. Rev. 69:1989;864-889.
128. Sulzer D., Maidment N.T., Rayport S. Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J. Neurochem. 60:1993;527-535.
129. Thompson T.L., Moore C.C., Smith B. Estrogen priming modulates autoreceptor-mediated potentiation of dopamine uptake. Eur. J. Pharmacol. 401:2000;357-363.
130. Thompson A.C., Zapata A., Justice J.B. Jr., Vaughan R.A., Sharpe L.G., Shippenberg T.S. Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine. J. Neurosci. 20:2000;9333-9340.
131. Thompson T.L., Bridges S.R., Weirs W.J. Alteration of dopamine transport in the striatum and nucleus accumbens of ovariectomized and estrogen-primed rats following N-(p-isothiocyanatophenethyl) spiperone (NIPS) treatment. Brain Res. Bull. 54:2001;631-638.
132. Torres G.E., Carneiro A., Seamans K., Fiorentini C., Sweeney A., Yao W.-D., Caron M.G. Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. J. Biol. Chem. 278:2003;2731-2739.
133. Torres G.E., Gainetdinov R.R., Caron M.G. Plasma membrane monoamine transporters: structure, regulation and function. Nat. Rev. Neurosci. 4:2003;13-25.
134. Vaughan R.A., Huff R.A., Uhl G.R., Kuhar M.J. Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes. J. Biol. Chem. 272:1997;15541-15546.
135. Volkow N.D., Fowler J.S., Wang G.J. Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. Behav. Pharmacol. 13:2002;355-366.
136. Weatherspoon J.K., Werling L.L. Modulation of amphetamine-stimulated. J. Pharmacol. Exp. Ther. 289:1999;278-284.
137. Wightman R.M., Amatore C., Engstrom R.C., Hale P.D., Kristensen E.W., Kuhr W.G., May L.J. Real-time characterization of dopamine overflow and uptake in the rat striatum. Neuroscience. 25:1988;513-523.
138. Wilson J.M., Levey A.I., Bergeron C., Kalasinsky K., Ang L., Peretti F., Adams V.I., Smialek J., Anderson W.R., Shannak K., Deck J., Niznik H.B., Kish S.J. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Ann. Neurol. 40:1996;428-439.
139. Wu Q., Reith M.E., Wightman R.M., Kawagoe K.T., Garris P.A. Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry. J. Neurosci. Methods. 112:2001;119-133.
140. Wu Q., Reith M.E., Walker Q.D., Kuhn C.M., Carroll F.I., Garris P.A. Concurrent autoreceptor-mediated control of dopamine release and uptake during neurotransmission: an in vivo voltammetric study. J. Neurosci. 22:2002;6272-6281.
141. Zahniser N.R., Doolen S. Chronic and acute regulation of Na+/Cl- dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol. Ther. 92:2001;21-55.
142. Zahniser N.R., Dickinson S.D., Gerhardt G.A. High-speed chronoamperometric electrochemical measurements of dopamine clearance. Methods Enzymol. 296:1998;708-719.
143. Zahniser N.R., Larson G.A., Gerhardt G.A. In vivo dopamine clearance rate in rat striatum: regulation by extracellular dopamine concentration and dopamine transporter inhibitors. J. Pharmacol. Exp. Ther. 289:1999;266-277.
144. Zapata A., Shippenberg T.S. D3 receptor ligands modulate extracellular dopamine clearance in the nucleus accumbens. J. Neurochem. 81:2002;1035-1042.
145. Zhang L., Coffey L.L., Reith M.E. Regulation of the functional activity of the human dopamine transporter by protein kinase C. Biochem. Pharmacol. 53:1997;677-688.
146. Zhang L., Elmer L.W., Little K.Y. Expression and regulation of the human dopamine transporter in a neuronal cell line. Brain Res. Mol. Brain. Res. 59:1998;66-73.
147. Zhu S.J., Kavanaugh M.P., Sonders M.S., Amara S.G., Zahniser N.R. Activation of protein kinase C inhibits uptake, currents and binding associated with the human dopamine transporter expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 282:1997;1358-1365.